Insights into the molecular pathogenesis of follicular lymphoma arising from analysis of geographic variation

Blood

Volumn 99, Issue 12, 2002, Pages 4265-4275

  Biagi, James J ^a   Seymour, John F ^a  

^a PETER MACCALLUM CANCER CENTRE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN BCL 2;

ASIA; CANCER EPIDEMIOLOGY; CARCINOGENESIS; CLINICAL FEATURE; FOLLICULAR LYMPHOMA; GENE FREQUENCY; GENE REARRANGEMENT; GENE TRANSLOCATION; GEOGRAPHIC DISTRIBUTION; GEOGRAPHIC PATHOLOGY; HUMAN; MEDICAL LITERATURE; PRIORITY JOURNAL; REVIEW; UNITED STATES;

EID: 0037097699     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V99.12.4265     Document Type: Review

References (133)

1. National Cancer Institute-sponsored study of classifications of non-Hodgkin's lymphomas: Summary and description of a working formulation for clinical usage. The Non-Hodgkin's Lymphoma Pathologic Classification Project
2. Statistical analyses of clinico-pathological, virological and epidemiological data on lymphoid malignancies with special reference to adult T-cell leukemia/lymphoma: A report of the second nationwide study of Japan: The T- and B-Cell Malignancy Study Group
3. Epidemiology of the non-Hodgkin's lymphomas: Distributions of the major subtypes differ by geographic locations. Non-Hodgkin's Lymphoma Classification Project
4. Malignant lymphoma in Manila - A clinicopathologic study at the University of the Philippines-Philippine General Hospital Medical Center
5. Malignant lymphomas in Korea
6. Non-Hodgkin's lymphoma in northern India: A retrospective analysis of 238 cases
7. Malignant lymphoma in Nebraska and Guangzhou, China: A comparative study
8. Clinico-pathological features of malignant lymphomas in 294 Hong Kong Chinese patients: Retrospective study covering an eight-year period
9. Non-Hodgkin's lymphomas in Thailand: A retrospective pathologic and clinical analysis of 1391 cases
10. Lymphoproliferative diseases in Japan and Western countries: Proceedings of the United States-Japan Seminar, September 6 and 7, 1982, in Seattle, Washington
11. Clinicopathologlc and immunophenotypic study of non-Hodgkin's lymphoma in Korea: Lymphoreticular Study Group of the Korean Society of Pathologists
12. REAL classification of malignant lymphomas in the Republic of Korea: Incidence of recently recognized entities and changes in clinicopathologic features: Hematolymphoreticular Study Group of the Korean Society of Pathologists: Revised European-American lymphoma
13. Leukaemias and lymphomas at Lucknow, India
14. Non-Hodgkin's lymphomas in Asia
15. Malignant lymphoma in Thailand: Changes in the frequency of malignant lymphoma determined from a histopathologic and immunophenotypic analysis of 425 cases at Siriraj Hospital
16. The pattern of malignant lymphoma in Oman
17. Non-Hodgkin's lymphoma - Clinicopathological pattern
18. Malignant lymphomas in Jos, Nigeria: A ten-year study
19. Malignant lymphomas in Gabon (equatorial Africa): A morphologic study of 72 cases
20. The incidence of non-Hodgkin's lymphoma and its histologic subtypes in Asian migrants to the United States and their descendants
21. Methodological problems in comparing incidence and prevalence of leukaemias and lymphomas: Ascertainment and age adjustment
22. Non-Hodgkin's lymphoma time trends: United States and international data
23. Annual report to the nation on the status of cancer (1973 through 1998), featuring cancers with recent increasing trends
24. The rise in incidence of lymphomas in Europe 1985-1992
25. Time trends of non-Hodgkin's lymphoma: Are they real? What do they mean?
26. Cancer surveillance series: Non-Hodgkin's lymphoma incidence by histologic subtype in the United States from 1978 through 1995
27. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: Report of the Clinical Advisory Committee Meeting: Airlie House, Virginia, November 1997
28. Criteria for the cytologic subclassification of follicular lymphomas: A proposed alternative method
29. Morphological subclassification of follicular lymphoma: Variability of diagnoses among hematopathologists, a collaborative study between the Repository Center and Pathology Panel for Lymphoma Clinical Studies
30. What should be the morphologic criteria for the subdivision of follicular lymphomas?
31. The epidemiology of non-Hodgkin's lymphoma: Comparison of nodal and extra-nodal sites
32. Increasing incidence of non-Hodgkin's lymphoma
33. Non-Hodgkin's lymphoma
34. Bcl-2 initiates a new category of oncogenes: Regulators of cell death
35. The proto-oncogene Bcl-2 and its role in regulating apoptosis
36. Molecular thanatopsis: A discourse on the BCL2 family and cell death
37. Cloning of the chromosome breakpoint of neoplastic B cells with the t(14;18) chromosome translocation
38. Analysis of the structure, transcripts, and protein products of bcl-2, the gene involved in human follicular lymphoma
39. Distinctive chromosomal abnormalities in histologic subtypes of non-Hodgkin's lymphoma
40. Bcl-2 expression promotes B- but not T-lymphoid development in SCID mice
41. bcl-2 immunoglobulin transgenic mice demonstrate extended B cell survival and follicular lymphoproliferation
42. Detection of minimal residual cells carrying the t(14;18) by DNA sequence amplification
43. Novel bcl-2 breakpoints in patients with follicular lymphoma
44. Characterisation of BCL2-JH rearrangements in follicular lymphoma: PCR detection of 3′ BCL2 breakpoints and evidence of a new cluster
45. Comparison of cytogenetic analysis, Southern analysis, and polymerase chain reaction for the detection of t(14;18) in follicular lymphoma
46. BCL2 gene activation and protein expression in follicular lymphoma: A report on 64 cases
47. bcl-2 expression in non-Hodgkin's lymphomas is not associated with bcl-2 gene rearrangements
48. Bcl-2 protein expression in follicular lymphomas in absence of 14;18 translocation
49. Expression in non-Hodgkin's lymphoma of the bcl-2 protein associated with the t(14;18) chromosomal translocation
50. Frequency of bcl-2 expression in non-Hodgkin's lymphoma: A study of 778 cases with comparison of marginal zone lymphoma and monocytoid B-cell hyperplasia
51. Bcl-2/JH rearrangements in benign lymphoid tissues with follicular hyperplasia
52. Detection of the t(14;18) at similar frequencies in hyperplastic lymphoid tissues from American and Japanese patients
53. Occurrence of bcl-2 oncogene translocation with increased frequency in the peripheral blood of heavy smokers
54. BCL-2/JH rearrangements in circulating B cells of healthy blood donors and patients with nonmalignant diseases
55. Quantification of t(14;18) in the lymphocytes of healthy adult humans as a possible biomarker for environmental exposures to carcinogens
56. Frequent detection of bcl-2/JH translocations in human blood and organ samples by a quantitative polymerase chain reaction assay
57. Lymphoma-associated translocation t(14;18) in blood B cells of normal individuals
58. BCL2 translocation frequency rises with age in humans
59. Amplified bcl-2/JH rearrangements in reactive lymphadenopathy
60. Detection of t(14;18) carrying cells in bone marrow and peripheral blood from patients affected by non-lymphoid diseases
61. Frequency of the Bcl-2/IgH rearrangement in normal individuals: Implications for the monitoring of disease in patients with follicular lymphoma
62. Multiple bcl-2/Ig gene rearrangements in persistent polyclonal B-cell lymphocytosis
63. The frequency of translocation t(14;18) in the peripheral blood of healthy individuals
64. Low frequency of BCL-2/J(H) translocation in peripheral blood lymphocytes of healthy Japanese individuals
65. Detection of the t(14;18) chromosomal translocation by interphase cytogenetics with yeast-artificial-chromosome probes in follicular lymphoma and nonneoplastic lymphoproliferation
66. Nucleotide sequence of a t(14;18) chromosomal breakpoint in follicular lymphoma and demonstration of a breakpoint-cluster region near a transcriptionally active locus on chromosome 18
67. Cloning the chromosomal breakpoint of t(14;18) human lymphomas: Clustering around JH on chromosome 14 and near a transcriptional unit on 18
68. The t(14;18) chromosome translocations involved in B-cell neoplasms result from mistakes in VDJ joining
69. Detection of additional JH/BCL2 translocations in follicular lymphoma
70. Absence of t(14;18) major and minor breakpoints and of Bcl-2 protein overproduction in Reed-Sternberg cells of Hodgkin's disease
71. Direct sequence analysis of the 14q+ and 18q- chromosome junctions in follicular lymphoma
72. Pre-B-cell leukemia with a t(8;14) and a t(14;18) translocation is preceded by follicular lymphoma
73. bcl-2 translocation in Japanese B cell lymphoma: Novel bcl-2 translocation with immunoglobulin heavy-chain diversity segment
74. Evolution of BCL-2/IgH hybrid gene RNA expression during treatment of T(14;18)-bearing follicular lymphomas
75. The epidemiology of non-Hodgkin's lymphoma in the northeast of Italy: A hospital-based case-control study
76. Smoking and risk of non-Hodgkin's lymphoma and multiple myeloma
77. Is cigarette smoking a risk factor for non-Hodgkin's lymphoma or multiple myeloma? Results from the Lutheran Brotherhood Cohort Study
78. Tobacco and non-Hodgkin's lymphoma: Combined analysis of three case-control studies (United States)
79. Cigarette smoking and risk of non-Hodgkin's lymphoma subtypes
80. Alcohol, tobacco and recreational drug use and the risk of non-Hodgkin's lymphoma
81. Geographic variance in the frequency of the t(14;18) translocation in follicular lymphoma: An Israeli series compared to the world
82. Correlation of bcl-2 rearrangement with clinical characteristics and outcome in indolent follicular lymphoma
83. Rearrangement of the BCL-2 gene in follicular lymphoma: Detection by PCR in both fresh and fixed tissue samples
84. Translocation of bcl-2 gene in non-Hodgkin's lymphomas in Hong Kong Chinese
85. Correlation between cytogenetic and molecular analysis of t(14;18) in follicular lymphomas
86. All advanced stage non-Hodgkin's lymphomas with a polymerase chain reaction amplifiable breakpoint of bcl-2 have residual cells containing the bcl-2 rearrangement at evaluation and after treatment
87. Classification and staging of lymphoma by molecular genetics
88. Incidence and prognostic significance of t(14;18) translocation in follicle center cell lymphoma of low and high grade: A report from southern Sweden
89. Translocation (14;18)-positive cells are present in the circulation of the majority of patients with localized (stage I and II) follicular non-Hodgkin's lymphoma
90. Investigation of BCL-2 gene rearrangements in a United Kingdom series of low and high grade non-Hodgkin's lymphomas
91. bcl-2 gene rearrangement analysis of Japanese follicular lymphomas by polymerase chain reaction in formalin-fixed, paraffin-embedded tissue specimens
92. The 14;18 translocation in European cases of follicular lymphoma: Comparison of Southern blotting and the polymerase chain reaction
93. Enhanced detection of the t(14;18) translocation in malignant lymphoma using pulsed-field gel electrophoresis
94. Gastric marginal zone B-cell lymphomas of MALT type develop along 2 distinct pathogenetic pathways
95. Clinical significance of the t(14;18) and BCL2 overexpression in follicular large cell lymphoma
96. Comparison of t(14;18) positive and t(14;18) negative follicular lymphoma (FL): Clinical characteristics, outcomes and cytogenetics
97. Nonrandom chromosome abnormalities in lymphoma
98. bcl-2 and other genomic alterations in the prognosis of large-cell lymphoma
99. Multiple recurrent genomic defects in follicular lymphoma: A possible model for cancer
100. Histologic transformation in follicular lymphoma
101. MYC rearrangements in histologically progressed follicular lymphomas
102. p16(INK4a) gene inactivation by deletions, mutations, and hypermethylation is associated with transformed and aggressive variants of non-Hodgkin's lymphomas
103. p53 mutation is associated with progression in follicular lymphomas
104. Alterations of a zinc finger-encoding gene, BCL-6, in diffuse large-cell lymphoma
105. LAZ3 rearrangements in non-Hodgkin's lymphoma: Correlation with histology, immunophenotype, karyotype, and clinical outcome in 217 patients
106. BCL-6 and other genomic alterations in non-Hodgkin's lymphoma (NHL)
107. Rearrangement of the bcl-6 gene as a prognostic marker in diffuse large-cell lymphoma
108. Rearrangements of the BCL6 gene in diffuse large cell non-Hodgkin's lymphoma
109. t(3;22)(q27;q11): A novel translocation associated with diffuse non-Hodgkin's lymphoma
110. Translocations involving band 3q27 and Ig gene regions in non-Hodgkin's lymphoma
111. Follicular lymphoma (FL) with BCL6 rearrangement: A lymphoma subtype with distinct pathological, molecular and clinical characteristics
112. Cytogenetic abnormalities predict clinical outcome in non-Hodgkin lymphoma
113. Prognostic value of chromosomal abnormalities in follicular lymphoma
114. Cytogenetic analysis of 434 consecutively ascertained specimens of non-Hodgkin's lymphoma: Correlations between recurrent aberrations, histology, and exposure to cytotoxic treatment
115. Serial determination of the bcl-2 gene in the bone marrow and peripheral blood after central lymphatic irradiation for stages I-III follicular lymphoma: A preliminary report
116. Sensitive and reproducible detection of occult disease in patients with follicular lymphoma by PCR amplification of t(14;18) both pre-and post-treatment
117. Detection of occult lymphoma in the peripheral blood and bone marrow of patients with untreated early-stage and advanced-stage follicular lymphoma
118. Persistence of circulating t(14;18)-positive cells in long-term remission after radiation therapy for localized-stage follicular lymphoma
119. The significance of circulating cells carrying t(14;18) in long remission from follicular lymphoma
120. The clinical significance of molecular response in indolent follicular lymphomas
121. Molecular response assessed by PCR is the most important factor predicting failure-free survival in indolent follicular lymphoma: Update of the MDACC series
122. Rituximab (anti-CD20 monoclonal antibody) as single first-line therapy for patients with follicular lymphoma with a low tumor burden: Clinical and molecular evaluation
123. Clinical relevance of bcl-2(MBR)/J(H) rearrangement detected by polymerase chain reaction in the peripheral blood of patients with follicular lymphoma
124. Clinical significance of t(14;18)-positive cells in the circulation of patients with stage III or IV follicular non-Hodgkin's lymphoma during first remission
125. The remission status before and the PCR status after high-dose therapy with peripheral blood stem cell support are prognostic factors for relapse-free survival in patients with follicular non-Hodgkin's lymphoma
126. Value of autologous stem cell transplantation with purged bone marrow as first-line therapy for follicular lymphoma with high tumor burden: A GOELAMS phase II study
127. Autologous stem cell transplantation (ASCT) with immunologically purged progenitor cells in patients with advanced stage follicular lymphoma after early partial or complete remission: Toxicity, follow-up of minimal residual disease and survival
128. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
129. Correlation between apoptosis microarray gene expression profiling and histopathological lymph node lesions
130. Gene expression profiling of follicular lymphoma and normal germinal center B cells using cDNA arrays
131. BCL6 and BCL2 rearrangement and p53 overexpression as prognostic factors in follicular lymphoma
132. High frequency of t(14;18)-translocation breakpoints outside of major breakpoint and minor cluster regions in follicular lymphomas: Improved polymerase chain reaction protocols for their detection